Etoricoxib 60 mg (Part I)/60 mg (Part II) | Etoricoxib 60 mg (Part I)/90 mg (Part II) | LS Mean Difference Between Etoricoxib 60 mg/90 mg vs. Etoricoxib 60 mg/60 mg; p-valuea | |
---|---|---|---|
LS Mean Change from Week 6 in PGAP over Weeks 10 and 12 | −11.96 (−14.96, −8.97) | −10.35 (−13.32, −7.39) | 1.61 (−0.49, 3.71); p = 0.327 |
LS Mean Change from Week 6 in PGART over Weeks 10 and 12 | 0.33 (0.19, 0.46) | 0.24 (0.10, 0.37) | −0.09 (−0.18, 0.00); p = 0.215 |
LS Mean Change from Week 6 in DAS28-CRP over Weeks 10 and 12 | −0.35 (−0.51, −0.18) | −0.39 (−0.55, −0.23) | −0.05 (−0.22, 0.13); p = 0.611 |